+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Transcatheter Heart Valve Market Size, Share & Trends Analysis Report by Application (Transcatheter Aortic Valve, Transcatheter Pulmonary Valve, Transcatheter Mitral Valve), Technology (Self-Expanded, Balloon Expanded) and Region with Growth Forecasts, 2025-2033- Product Image
Transcatheter Heart Valve Market Size, Share & Trends Analysis Report by Application (Transcatheter Aortic Valve, Transcatheter Pulmonary Valve, Transcatheter Mitral Valve), Technology (Self-Expanded, Balloon Expanded) and Region with Growth Forecasts, 2025-2033- Product Image
New

Transcatheter Heart Valve Market Size, Share & Trends Analysis Report by Application (Transcatheter Aortic Valve, Transcatheter Pulmonary Valve, Transcatheter Mitral Valve), Technology (Self-Expanded, Balloon Expanded) and Region with Growth Forecasts, 2025-2033

  • PDF Icon

    Report

  • 120 Pages
  • November 2025
  • Region: Global
  • Grand View Research
  • ID: 5921064
REQUEST CUSTOMIZATION
Description Jump to:
The global transcatheter heart valve market size was estimated at USD 5.49 billion in 2024 and projected to reach USD 21.24 billion by 2033, growing at a CAGR of 16.49% from 2025 to 2033. The rising prevalence of heart valve diseases, particularly in the aging population, is driving the demand for transcatheter heart valve (THV) procedures, such as TAVR, especially for conditions such as aortic stenosis and mitral regurgitation.

Key factors propelling the growth of the transcatheter heart valve industry include continuous improvements in THV design, advancements in imaging and delivery systems, and the increasing preference for minimally invasive surgeries, which offer shorter recovery times, reduced complications, and lower healthcare costs compared to traditional open-heart surgery.

In September 2024, the CDC reported that 75% of adults in the U.S. have limited knowledge about heart valve disease. This lack of awareness extends to high-risk groups, particularly individuals aged 65 and older. Each year, over 5 million people in the U.S. receive a diagnosis of heart valve disease, contributing to more than 25,000 fatalities attributed to this condition annually.

The growing prevalence of heart valve diseases, particularly in the aging population, significantly drives the demand for transcatheter heart valve (THV) procedures. Conditions such as aortic stenosis and mitral regurgitation are becoming more common, necessitating advanced treatment solutions such as THVs. In September 2024, the CDC reported that 75% of adults in the U.S. have limited knowledge about heart valve disease. This lack of awareness extends to high-risk groups, particularly individuals aged 65 and older. Each year, over 5 million people in the U.S. receive a diagnosis of heart valve disease, contributing to more than 25,000 fatalities attributed to this condition annually.

Continuous improvements in THV design, including enhanced valve durability, ease of implantation, and improved patient outcomes, are crucial drivers. Advancements in imaging techniques and valve delivery systems have also significantly improved procedural success and expanded the patient pool eligible for THV procedures. In August 2024, Boston Scientific announced that its ACURATE Prime Aortic Valve System has received CE mark approval. This state-of-the-art transcatheter aortic valve replacement system features a new valve size to serve patients with larger anatomies and is indicated for individuals at low, intermediate, and high risk experiencing severe aortic stenosis. The system features a self-expanding design and a refined deployment mechanism, enhancing the accuracy of valve positioning to improve overall patient outcomes.

Global Transcatheter Heart Valve Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global transcatheter heart valve market report based on application, technology, and region:

Application Outlook (Revenue, USD Million, 2021-2033)

  • Transcatheter Aortic Valve
  • Transcatheter Pulmonary Valve
  • Transcatheter Mitral Valve

Technology Outlook (Revenue, USD Million, 2021-2033)

  • Balloon Expanded Transcatheter Valve
  • Self-Expanded Transcatheter Valve

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa (MEA)

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Application
1.2.2. Technology
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia-Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application outlook
2.2.2. Technology outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Transcatheter Heart Valve Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising prevalence of valvular heart diseases and aging population
3.2.1.2. Increasing preference for minimally invasive cardiac procedures
3.2.1.3. Technological advancements in valve design and delivery systems
3.2.2. Market restraint analysis
3.2.2.1. High procedural and device costs limiting accessibility
3.2.2.2. Complications related to valve durability and thrombosis risk
3.2.3. Market developments
3.2.3.1. Key clinical trials in the transcatheter heart valve market, by region
3.2.3.2. Recent product launches in the transcatheter heart valve market, by region
3.2.3.3. Emerging products in the transcatheter heart valve market, by region
3.2.4. Competitive factors and strategies
3.2.4.1. Clinical insights
3.2.4.2. Emerging technologies
3.2.4.3. Market appeal
3.2.4.4. Physician training and marketing
3.2.4.5. Product improvements and innovations
3.2.4.6. Mergers, acquisitions, and partnerships
3.2.4.7. Product portfolio management
3.3. Transcatheter Heart Valve Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Transcatheter Heart Valve Market: Application Estimates & Trend Analysis
4.1. Definition and Scope
4.2. Application Market Share Analysis, 2024 & 2033
4.3. Segment Dashboard
4.4. Transcatheter Aortic Valve
4.4.1. Transcatheter aortic valve market estimates and forecasts 2021 to 2033 (USD Million)
4.5. Transcatheter Pulmonary Valve
4.5.1. Transcatheter pulmonary valve market estimates and forecasts 2021 to 2033 (USD Million)
4.6. Transcatheter Mitral Valve
4.6.1. Transcatheter mitral valve market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. Transcatheter Heart Valve Market: Technology Estimates & Trend Analysis
5.1. Definition and Scope
5.2. Application Market Share Analysis, 2024 & 2033
5.3. Segment Dashboard
5.4. Balloon Expanded Transcatheter Valve
5.4.1. Balloon expanded transcatheter valve market estimates and forecasts 2021 to 2033 (USD Million)
5.5. Self-Expanded Transcatheter Valve
5.5.1. Self-expanded transcatheter valve market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Transcatheter Heart Valve Market: Regional Estimates & Trend Analysis by Application and Technology
6.1. Regional Dashboard
6.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
6.3. North America
6.3.1. U.S.
6.3.1.1. Key country dynamics
6.3.1.2. Regulatory framework/ reimbursement structure
6.3.1.3. Competitive scenario
6.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
6.3.2. Canada
6.3.2.1. Key country dynamics
6.3.2.2. Regulatory framework/ reimbursement structure
6.3.2.3. Competitive scenario
6.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
6.3.3. Mexico
6.3.3.1. Key country dynamics
6.3.3.2. Regulatory framework/ reimbursement structure
6.3.3.3. Competitive scenario
6.3.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Key country dynamics
6.4.1.2. Regulatory framework/ reimbursement structure
6.4.1.3. Competitive scenario
6.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
6.4.2. Germany
6.4.2.1. Key country dynamics
6.4.2.2. Regulatory framework/ reimbursement structure
6.4.2.3. Competitive scenario
6.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
6.4.3. France
6.4.3.1. Key country dynamics
6.4.3.2. Regulatory framework/ reimbursement structure
6.4.3.3. Competitive scenario
6.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
6.4.4. Italy
6.4.4.1. Key country dynamics
6.4.4.2. Regulatory framework/ reimbursement structure
6.4.4.3. Competitive scenario
6.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
6.4.5. Spain
6.4.5.1. Key country dynamics
6.4.5.2. Regulatory framework/ reimbursement structure
6.4.5.3. Competitive scenario
6.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
6.4.6. Norway
6.4.6.1. Key country dynamics
6.4.6.2. Regulatory framework/ reimbursement structure
6.4.6.3. Competitive scenario
6.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
6.4.7. Sweden
6.4.7.1. Key country dynamics
6.4.7.2. Regulatory framework/ reimbursement structure
6.4.7.3. Competitive scenario
6.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
6.4.8. Denmark
6.4.8.1. Key country dynamics
6.4.8.2. Regulatory framework/ reimbursement structure
6.4.8.3. Competitive scenario
6.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
6.5. Asia-Pacific
6.5.1. Japan
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/ reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
6.5.2. China
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
6.5.3. India
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
6.5.4. Australia
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/ reimbursement structure
6.5.4.3. Competitive scenario
6.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
6.5.5. South Korea
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework/ reimbursement structure
6.5.5.3. Competitive scenario
6.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
6.5.6. Thailand
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework/ reimbursement structure
6.5.6.3. Competitive scenario
6.5.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/ reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
6.6.2. Argentina
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
6.7. MEA
6.7.1. South Africa
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/ reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
6.7.2. Saudi Arabia
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
6.7.3. UAE
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/ reimbursement structure
6.7.3.3. Competitive scenario
6.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
6.7.4. Kuwait
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/ reimbursement structure
6.7.4.3. Competitive scenario
6.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company/Competition Categorization
7.2. Vendor Landscape
7.2.1. Key company market share analysis, 2024
7.2.2. Medtronic
7.2.2.1. Overview
7.2.2.2. Financial Performance
7.2.2.3. Product Benchmarking
7.2.2.4. Strategic Initiatives
7.2.3. Abbott
7.2.3.1. Overview
7.2.3.2. Financial Performance
7.2.3.3. Product Benchmarking
7.2.3.4. Strategic Initiatives
7.2.4. Braile Biomédica
7.2.4.1. Overview
7.2.4.2. Financial Performance
7.2.4.3. Product Benchmarking
7.2.4.4. Strategic Initiatives
7.2.5. Meril Life Sciences Pvt. Ltd., Inc.
7.2.5.1. Overview
7.2.5.2. Financial Performance
7.2.5.3. Product Benchmarking
7.2.5.4. Strategic Initiatives
7.2.6. Edwards Lifesciences Corporation
7.2.6.1. Overview
7.2.6.2. Financial Performance
7.2.6.3. Product Benchmarking
7.2.6.4. Strategic Initiatives
7.2.7. MicroPort Scientific Corporation
7.2.7.1. Overview
7.2.7.2. Financial Performance
7.2.7.3. Product Benchmarking
7.2.7.4. Strategic Initiatives
7.2.8. Venus Medtech (Hangzhou) Inc.
7.2.8.1. Overview
7.2.8.2. Financial Performance
7.2.8.3. Product Benchmarking
7.2.8.4. Strategic Initiatives
7.2.9. JenaValve
7.2.9.1. Overview
7.2.9.2. Financial Performance
7.2.9.3. Product Benchmarking
7.2.9.4. Strategic Initiatives
7.2.10. Biosensors International Group, Ltd
7.2.10.1. Overview
7.2.10.2. Financial Performance
7.2.10.3. Product Benchmarking
7.2.10.4. Strategic Initiatives
7.2.11. HLT Medical (Bracco)
7.2.11.1. Overview
7.2.11.2. Financial Performance
7.2.11.3. Product Benchmarking
7.2.11.4. Strategic Initiatives
List of Tables
Table 1 List of abbreviations
Table 2 North America transcatheter heart valve market, by region, 2021-2033 (USD Million)
Table 3 North America transcatheter heart valve market, by application, 2021-2033 (USD Million)
Table 4 North America transcatheter heart valve market, by technology, 2021-2033 (USD Million)
Table 5 U.S. transcatheter heart valve market, by application, 2021-2033 (USD Million)
Table 6 U.S. transcatheter heart valve market, by technology, 2021-2033 (USD Million)
Table 7 Canada transcatheter heart valve market, by application, 2021-2033 (USD Million)
Table 8 Canada transcatheter heart valve market, by technology, 2021-2033 (USD Million)
Table 9 Mexico transcatheter heart valve market, by application, 2021-2033 (USD Million)
Table 10 Mexico transcatheter heart valve market, by technology, 2021-2033 (USD Million)
Table 11 Europe transcatheter heart valve market, by region, 2021-2033 (USD Million)
Table 12 Europe transcatheter heart valve market, by application, 2021-2033 (USD Million)
Table 13 Europe transcatheter heart valve market, by technology, 2021-2033 (USD Million)
Table 14 Germany transcatheter heart valve market, by application, 2021-2033 (USD Million)
Table 15 Germany transcatheter heart valve market, by technology, 2021-2033 (USD Million)
Table 16 UK transcatheter heart valve market, by application, 2021-2033 (USD Million)
Table 17 UK transcatheter heart valve market, by technology, 2021-2033 (USD Million)
Table 18 France transcatheter heart valve market, by application, 2021-2033 (USD Million)
Table 19 France transcatheter heart valve market, by technology, 2021-2033 (USD Million)
Table 20 Italy transcatheter heart valve market, by application, 2021-2033 (USD Million)
Table 21 Italy transcatheter heart valve market, by technology, 2021-2033 (USD Million)
Table 22 Spain transcatheter heart valve market, by application, 2021-2033 (USD Million)
Table 23 Spain transcatheter heart valve market, by technology, 2021-2033 (USD Million)
Table 24 Denmark transcatheter heart valve market, by application, 2021-2033 (USD Million)
Table 25 Denmark transcatheter heart valve market, by technology, 2021-2033 (USD Million)
Table 26 Sweden transcatheter heart valve market, by application, 2021-2033 (USD Million)
Table 27 Sweden transcatheter heart valve market, by technology, 2021-2033 (USD Million)
Table 28 Norway transcatheter heart valve market, by application, 2021-2033 (USD Million)
Table 29 Norway transcatheter heart valve market, by technology, 2021-2033 (USD Million)
Table 30 Asia-Pacific transcatheter heart valve market, by region, 2021-2033 (USD Million)
Table 31 Asia-Pacific transcatheter heart valve market, by application, 2021-2033 (USD Million)
Table 32 Asia-Pacific transcatheter heart valve market, by technology, 2021-2033 (USD Million)
Table 33 China transcatheter heart valve market, by application, 2021-2033 (USD Million)
Table 34 China transcatheter heart valve market, by technology, 2021-2033 (USD Million)
Table 35 Japan transcatheter heart valve market, by application, 2021-2033 (USD Million)
Table 36 Japan transcatheter heart valve market, by technology, 2021-2033 (USD Million)
Table 37 India transcatheter heart valve market, by application, 2021-2033 (USD Million)
Table 38 India transcatheter heart valve market, by technology, 2021-2033 (USD Million)
Table 39 South Korea transcatheter heart valve market, by application, 2021-2033 (USD Million)
Table 40 South Korea transcatheter heart valve market, by technology, 2021-2033 (USD Million)
Table 41 Australia transcatheter heart valve market, by application, 2021-2033 (USD Million)
Table 42 Australia transcatheter heart valve market, by technology, 2021-2033 (USD Million)
Table 43 Thailand transcatheter heart valve market, by application, 2021-2033 (USD Million)
Table 44 Thailand transcatheter heart valve market, by technology, 2021-2033 (USD Million)
Table 45 Latin America transcatheter heart valve market, by region, 2021-2033 (USD Million)
Table 46 Latin America transcatheter heart valve market, by application, 2021-2033 (USD Million)
Table 47 Latin America transcatheter heart valve market, by technology, 2021-2033 (USD Million)
Table 48 Brazil transcatheter heart valve market, by application, 2021-2033 (USD Million)
Table 49 Brazil transcatheter heart valve market, by technology, 2021-2033 (USD Million)
Table 50 Argentina transcatheter heart valve market, by application, 2021-2033 (USD Million)
Table 51 Argentina transcatheter heart valve market, by technology, 2021-2033 (USD Million)
Table 52 MEA transcatheter heart valve market, by region, 2021-2033 (USD Million)
Table 53 MEA transcatheter heart valve market, by application, 2021-2033 (USD Million)
Table 54 MEA transcatheter heart valve market, by technology, 2021-2033 (USD Million)
Table 55 South Africa transcatheter heart valve market, by application, 2021-2033 (USD Million)
Table 56 South Africa transcatheter heart valve market, by technology, 2021-2033 (USD Million)
Table 57 Saudi Arabia transcatheter heart valve market, by application, 2021-2033 (USD Million)
Table 58 Saudi Arabia transcatheter heart valve market, by technology, 2021-2033 (USD Million)
Table 59 UAE transcatheter heart valve market, by application, 2021-2033 (USD Million)
Table 60 UAE transcatheter heart valve market, by technology, 2021-2033 (USD Million)
Table 61 Kuwait transcatheter heart valve market, by application, 2021-2033 (USD Million)
Table 62 Kuwait transcatheter heart valve market, by technology, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Transcatheter heart valve market: outlook
Figure 9 Transcatheter heart valve competitive insights
Figure 10 Ancillary market outlook
Figure 11 Transcatheter heart valve market driver impact
Figure 12 Transcatheter heart valve market restraint impact
Figure 13 Porter’s Analysis
Figure 14 PESTLE Analysis
Figure 15 Transcatheter heart valve market: Application movement analysis
Figure 16 Transcatheter heart valve market: Application outlook and key takeaways
Figure 17 Transcatheter aortic valve market estimates and forecast, 2021-2033 (USD Million)
Figure 18 Transcatheter pulmonary valve market estimates and forecast, 2021-2033 (USD Million)
Figure 19 Transcatheter mitral valve market estimates and forecast, 2021-2033 (USD Million)
Figure 20 Transcatheter heart valve market: Technology movement analysis
Figure 21 Transcatheter heart valve market: Technology outlook and key takeaways
Figure 22 Balloon expanded transcatheter valve market estimates and forecast, 2021-2033 (USD Million)
Figure 23 Self-expanded transcatheter valve market estimates and forecast, 2021-2033 (USD Million)
Figure 24 Global transcatheter heart valve market: Regional movement analysis
Figure 25 Global transcatheter heart valve market: Regional outlook and key takeaways
Figure 26 North America, by country
Figure 27 North America market estimates and forecasts, 2021-2033 (USD Million)
Figure 28 U.S. key country dynamics
Figure 29 U.S. market estimates and forecasts, 2021-2033 (USD Million)
Figure 30 Canada key country dynamics
Figure 31 Canada market estimates and forecasts, 2021-2033 (USD Million)
Figure 32 Mexico key country dynamics
Figure 33 Mexico market estimates and forecasts, 2021-2033 (USD Million)
Figure 34 Europe market estimates and forecasts, 2021-2033 (USD Million)
Figure 35 UK key country dynamics
Figure 36 UK market estimates and forecasts, 2021-2033 (USD Million)
Figure 37 Germany key country dynamics
Figure 38 Germany market estimates and forecasts, 2021-2033 (USD Million)
Figure 39 France key country dynamics
Figure 40 France market estimates and forecasts, 2021-2033 (USD Million)
Figure 41 Italy key country dynamics
Figure 42 Italy market estimates and forecasts, 2021-2033 (USD Million)
Figure 43 Spain key country dynamics
Figure 44 Spain market estimates and forecasts, 2021-2033 (USD Million)
Figure 45 Denmark key country dynamics
Figure 46 Denmark market estimates and forecasts, 2021-2033 (USD Million)
Figure 47 Sweden key country dynamics
Figure 48 Sweden market estimates and forecasts, 2021-2033 (USD Million)
Figure 49 Norway key country dynamics
Figure 50 Norway market estimates and forecasts, 2021-2033 (USD Million)
Figure 51 Asia-Pacific market estimates and forecasts, 2021-2033 (USD Million)
Figure 52 China key country dynamics
Figure 53 China market estimates and forecasts, 2021-2033 (USD Million)
Figure 54 Japan key country dynamics
Figure 55 Japan market estimates and forecasts, 2021-2033 (USD Million)
Figure 56 India key country dynamics
Figure 57 India market estimates and forecasts, 2021-2033 (USD Million)
Figure 58 Thailand key country dynamics
Figure 59 Thailand market estimates and forecasts, 2021-2033 (USD Million)
Figure 60 South Korea key country dynamics
Figure 61 South Korea market estimates and forecasts, 2021-2033 (USD Million)
Figure 62 Australia key country dynamics
Figure 63 Australia market estimates and forecasts, 2021-2033 (USD Million)
Figure 64 Latin America market estimates and forecasts, 2021-2033 (USD Million)
Figure 65 Brazil key country dynamics
Figure 66 Brazil market estimates and forecasts, 2021-2033 (USD Million)
Figure 67 Argentina key country dynamics
Figure 68 Argentina market estimates and forecasts, 2021-2033 (USD Million)
Figure 69 Middle East and Africa market estimates and forecasts, 2021-2033 (USD Million)
Figure 70 South Africa key country dynamics
Figure 71 South Africa market estimates and forecasts, 2021-2033 (USD Million)
Figure 72 Saudi Arabia key country dynamics
Figure 73 Saudi Arabia market estimates and forecasts, 2021-2033 (USD Million)
Figure 74 UAE key country dynamics
Figure 75 UAE market estimates and forecasts, 2021-2033 (USD Million)
Figure 76 Kuwait key country dynamics
Figure 77 Kuwait market estimates and forecasts, 2021-2033 (USD Million)
Figure 78 Key company categorization
Figure 79 Heat map analysis 2024

Companies Mentioned

The key companies profiled in this Transcatheter Heart Valve market report include:
  • Medtronic
  • Abbott
  • Braile Biomédica
  • Meril Life Sciences Pvt. Ltd., Inc.
  • Edwards Lifesciences Corporation
  • MicroPort Scientific Corporation
  • Venus Medtech (Hangzhou) Inc.
  • JenaValve
  • Biosensors International Group, Ltd
  • HLT Medical (Bracco)

Table Information

Report AttributeDetails
No. of Pages120
PublishedNovember 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 5.49 Billion
Forecasted Market Value ( USD ) by 2033 $ 21.24 Billion
Compound Annual Growth Rate16.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Prosthetic Heart Valve & Artificial Heart Valve Market - Global Forecast 2025-2030 - Product Image

Prosthetic Heart Valve & Artificial Heart Valve Market - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Polymer Heart Valves Market - Global Forecast 2025-2030 - Product Image

Polymer Heart Valves Market - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Transcatheter Heart Valves - Global Strategic Business Report - Product Image

Transcatheter Heart Valves - Global Strategic Business Report

  • Report
  • 247 Pages
  • Global
From
Transcatheter Heart Valve Replacement and Repair Market Report and Forecast 2025-2034 - Product Image

Transcatheter Heart Valve Replacement and Repair Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From
Prosthetic Heart Valves - Global Strategic Business Report - Product Image

Prosthetic Heart Valves - Global Strategic Business Report

  • Report
  • 297 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.